Moreover, peroxidasin has been previously discovered in lower organisms to stabilize or seal ECM by collagen IV crosslinking [73,74,75], and such a genetic defect is also implied in the human setting [76,77], suggesting an exciting target to study in the role of matrix defects in the pathogenesis of PDA [78,79]. This evidence concerns the gene PXDN and Patent ductus arteriosus.